Metabolic Phenotypes of Response to Vaccination in Humans.
Li, Shuzhao; Sullivan, Nicole L; Rouphael, Nadine; Yu, Tianwei; Banton, Sophia; Maddur, Mohan S; McCausland, Megan; Chiu, Christopher; Canniff, Jennifer; Dubey, Sheri; Liu, Ken; Tran, ViLinh; Hagan, Thomas; Duraisingham, Sai; Wieland, Andreas; Mehta, Aneesh K; Whitaker, Jennifer A; Subramaniam, Shankar; Jones, Dean P; Sette, Alessandro; Vora, Kalpit; Weinberg, Adriana; Mulligan, Mark J; Nakaya, Helder I; Levin, Myron; Ahmed, Rafi; Pulendran, Bali.
; 169(5): 862-877.e17, 2017 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-28502771
Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group.
Herpes Zoster Vaccination: Controversies and Common Clinical Questions.
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years.
Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies.
Herpes Zoster Vaccine in the Long-Term Care Setting: A Clinical and Logistical Conundrum.
Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.
A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.